Capell WH, Barnathan ES, Piazza G, Spyropoulos AC, et al. Rationale and Design for the Study of Rivaroxaban to Reduce Thrombotic Events, Hospitalization and Death in Outpatients with COVID-19: the PREVENT-HD Study. Am Heart J 2021 Feb 9. pii: S0002-8703(21)00033.
PMID: 33577800